CASPODAS caspofungin (as acetate) 70mg powder for injection vial

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

caspofungin acetate, Quantity: 77.7 mg

Verfügbar ab:

MedTAS Pty Ltd

INN (Internationale Bezeichnung):

caspofungin acetate

Darreichungsform:

Injection, powder for

Zusammensetzung:

Excipient Ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid

Verabreichungsweg:

Intravenous

Einheiten im Paket:

1 vial

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

CASPODAS is indicated for: ? Empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? Treatment of: - Invasive Candidiasis, including candidaemia - Oesophageal Candidiasis - Invasive Aspergillosis in patients who are refractory to or intolerant of other therapies.

Produktbesonderheiten:

Visual Identification: Lyophilized white to off-white cake or powder; Container Type: Vial; Container Material: Glass; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2017-04-19